Literature DB >> 25305373

The spectrum of opportunistic diseases complicating sarcoidosis.

Yvan Jamilloux, Dominique Valeyre, Olivier Lortholary, Claire Bernard, Sébastien Kerever, Lucie Lelievre, Antoine Neel, Christiane Broussolle, Pascal Seve.   

Abstract

Sarcoidosis is an inflammatory disease marked by a paradoxical immune status. The anergic state, which results from various immune defects, contrasts with the inflammatory formation of granulomas. Sarcoidosis patients may be at risk for opportunistic infections (OIs) and a substantial number of cases have been reported, even in untreated sarcoidosis. It is not clear how OIs in patients with sarcoidosis are different from other groups at risk. In this review, we discuss the most common OIs: mycobacterial infection (including tuberculosis), cryptococcosis, progressive multifocal leukoencephalopathy, and aspergillosis. Unlike peripheral lymphocytopenia, corticosteroids are a major risk factor for OIs but the occurrence of Ols in untreated patients suggests more complex predisposing mechanisms. Opportunistic infections presenting with extrapulmonary features are often misdiagnosed as new localizations of sarcoidosis. Aspergillomas mostly develop on fibrocystic lungs. Overall, physicians should be aware of the possible occurrence of OIs during sarcoidosis, even in untreated patients.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25305373     DOI: 10.1016/j.autrev.2014.10.006

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  10 in total

1.  Progressive multifocal leukoencephalopathy in a patient with silicosis.

Authors:  Alexandre Bonnet; Anne Kerbrat; Pierre Tattevin; Anne Salmon; Stéphane Jouneau; Gilles Edan; Jacques Gasnault
Journal:  J Neurol       Date:  2016-07-14       Impact factor: 4.849

2.  Cryptococcal meningitis in a patient with sarcoidosis.

Authors:  Traci N Adams; Maeghan Gibson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-04

Review 3.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 4.  Catch the rainbow: Prognostic factor of sarcoidosis.

Authors:  Senol Kobak
Journal:  Lung India       Date:  2020 Sep-Oct

5.  Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximab.

Authors:  Sina C Rosenkranz; Vivien Häußler; Manuela Kolster; Anne Willing; Jakob Matschke; Christoph Röcken; Klarissa Stürner; Frank Leypoldt; Eva Tolosa; Manuel A Friese
Journal:  Brain Commun       Date:  2021-12-16

6.  Central Nervous System Cryptococcosis in Patients With Sarcoidosis: Comparison With Non-sarcoidosis Patients and Review of Potential Pathophysiological Mechanisms.

Authors:  Renaud Prevel; Vivien Guillotin; Sébastien Imbert; Patrick Blanco; Laurence Delhaes; Pierre Duffau
Journal:  Front Med (Lausanne)       Date:  2022-03-29

7.  Anti-inflammatory Properties of the Alpha-Melanocyte-Stimulating Hormone in Models of Granulomatous Inflammation.

Authors:  Abdolrazagh Hashemi Shahraki; Runxia Tian; Chongxu Zhang; Nevis L Fregien; Pablo Bejarano; Mehdi Mirsaeidi
Journal:  Lung       Date:  2022-06-18       Impact factor: 3.777

8.  Posterior fossa progressive multifocal leukoencephalopathy: first presentation of an unknown autoimmune disease.

Authors:  Paulette Scholten; Peter Kralt; Bram Jacobs
Journal:  BMJ Case Rep       Date:  2017-10-11

9.  Severe infections in sarcoidosis: Incidence, predictors and long-term outcome in a cohort of 585 patients.

Authors:  Amélie Duréault; Catherine Chapelon; Lucie Biard; Fanny Domont; Léa Savey; Bahram Bodaghi; Valérie Pourcher; Matthieu Resche Rigon; Patrice Cacoub; David Saadoun
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 10.  Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy.

Authors:  Huzaefah Syed; Christian Ascoli; Catharina Fm Linssen; Christen Vagts; Thomas Iden; Aamer Syed; Jordana Kron; Kelly Polly; David Perkins; Patricia W Finn; Richard Novak; Marjolein Drent; Robert Baughman; Nadera J Sweiss
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-06-30       Impact factor: 0.670

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.